PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-05-22

Date Title Company
22-May-2024 Xenetic Biosciences, Inc. Announces Executive Leadership Transition AccessWire
22-May-2024 Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29 AccessWire
22-May-2024 InDevR Introduces Latest Solution for Influenza Vaccine Manufacturers, OmniFlu HA, to Simplify Vaccine Testing and Speed Time to Market AccessWire
22-May-2024 InDevR Introduces Latest Solution for Influenza Vaccine Manufacturers, OmniFlu HA, to Simplify Vaccine Testing and Speed Time to Market Newswire
22-May-2024 Report from the Annual General Meeting 2024 of IRLAB Therapeutics AB AccessWire
22-May-2024 HealthJoy Celebrates 10 Years of Bringing Benefits to Life AccessWire
22-May-2024 Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation AccessWire
22-May-2024 Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers in Lung Fibrosis Brainomix
22-May-2024 Invizius’s Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study Invizius Limited
22-May-2024 Rotherham enhances patient access with launch of innovative digital diagnostic booking service Netcall
22-May-2024 BaseLaunch announces a new partnership with AbbVie BaseLaunch
22-May-2024 NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb NeoPhore Limited
22-May-2024 Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities Asymchem
22-May-2024 Everfur Launches Fur-Forward Diagnostics Kit: Pioneering Pet Health Monitoring With Advanced Metabolomics AccessWire
22-May-2024 Refeyn strengthens capability with new US Headquarters in Boston area Refeyn
22-May-2024 Genmab Completes Acquisition of ProfoundBio Genmab
22-May-2024 New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation, and save time CAS
22-May-2024 Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market AccessWire
22-May-2024 Assured Allies Announces a Multi-Year Partnership to Support CalPERS Long-Term Care Policyholders in Maintaining Their Independence AccessWire
22-May-2024 Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway Molecure S.A.